Status:
COMPLETED
Nutritional Treatment for the Amelioration of Traumatic Brain Injury
Lead Sponsor:
Queen Mary University of London
Conditions:
Traumatic Brain Injury
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
To test the feasibility of administering a commercially available neurotrophic oral nutritional supplement (ONS) for adult patients with acute traumatic brain injury at the Royal London Hospital.
Detailed Description
The study will be a randomised controlled non-blinded trial of adult patients with acute traumatic brain injury at the Royal London Hospital. There will be randomisation to one of two non-blinded tri...
Eligibility Criteria
Inclusion
- Adult between 18 yrs and 80 yrs of age
- Acute traumatic brain injury with confirmed radiological features
Exclusion
- Allergies to fish oil/milk/soya
- Medical history of galactosaemia
- Non-traumatic aetiology to head injury
- Unable to receive enteral nutrition
- Craniectomy during admission (loss of integrity of skull convexity)
- Concurrent active neurological disease
- Pregnancy or breastfeeding
Key Trial Info
Start Date :
October 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04418440
Start Date
October 14 2021
End Date
April 30 2024
Last Update
November 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bart Health, Royal London Hospital
London, United Kingdom, E1 1FR